---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-070186"
form_type: "8-K/A"
ticker: "YHC"
cik: "0001843165"
company_name: "LQR House Inc."
filed_at: "2023-08-23T23:59:59+00:00"
generated_at: "2026-06-11T04:58:51.553346+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Appoints Jay Dhaliwal to Board; Launches Preliminary Naked Short Selling Investigation

## Summary
- Jay Dhaliwal appointed to Board effective Aug 21, 2023, increasing board from 7 to 8 members.
- Dhaliwal is independent; current CEO of Global Health Clinics and interim CEO of Ravenquest Biomed; serves on several public company boards.
- LQR House will conduct preliminary investigation into possible naked short selling and manipulation of its common shares on NASDAQ.
- Company enters standard indemnity and director agreements, and restricted stock unit award agreement with Dhaliwal.

## SEC filing metadata
- accession: 0001213900-23-070186
- form_type: 8-K/A
- ticker: YHC
- cik: 0001843165
- company_name: LQR House Inc.
- filed_at: 2023-08-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1843165/000121390023070186/0001213900-23-070186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1843165/000121390023070186/ea184091-8ka1_lqrhouse.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-070186
- JSON: https://secwatch.observer/filing/0001213900-23-070186.json
- Plain text: https://secwatch.observer/filing/0001213900-23-070186.txt

## Key facts
- Executive change
  Jatinder (Jay) Dhaliwal was appointed as member of the Board of Directors at LQR House Inc..
  - Action: appointed
  - Role: member of the Board of Directors
  source text: On August 21, 2023, the Board appointed Jatinder (Jay) Dhaliwal as a member of the Board of Directors (the “Board”), effective August 21, 2023, increasing the number of directors from seven (7) to eight (8).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1843165/000121390023070186/0001213900-23-070186-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.